Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

10 ArticlesDRREDDY

1 / 1

Dr Reddy’s USFDA Inspection of Oncology Formulation Manufacturing Facility at Duvvada – Form 483 Revealed

Today we cover the Form 483 issued by the US FDA to Dr. Reddy’s oncology formulation manufacturing facility at Duvvada at Visakhapatnam, Andhra Pradesh. ...
Dr-Reddy-Duvvada-1.png

Dr Reddy’s Laboratories US FDA Inspection of Miryalaguda – Form 483 Revealed

Today we cover the Form 483 issued by the US FDA to Dr. Reddy’s API manufacturing plant at Miryalaguda. On another note, the company’s formulation ...
Dr-Reddy-Miryalguda-2.png

Earnings Report: 3QFY17 : 495 Companies Till Now With Management Comments

Here is a quick summary of the third quarter financial results for all the companies announced till date. For some companies, management comments have been ...
Sectoral-10022017.png

FDA’s New Rules Propels Generic and Biosimilar Approvals

Effective January 9th 2017, the US Food and Drug Administration (FDA) has announced an amendment to the final rule ((the rule governs the manner in which FDA ...
Original-Abbreviated-New-Drug-Application-ANDA-Approvals-10-November-2016.png

Result Analysis: Dr Reddys Q1 Net Profit Dives By 76.29%

The big boy of the pharma sector, Dr. Reddys Laboratories has come out with its Q1 results for 2016. The results have not been taken well by investors and the ...
DrReddys-Company-Logo.png

Dr. Reddy's Laboratories recalls 84,240 bottles of Acid Controller tablets

Drug major Dr. Reddy’s Laboratories Inc. (the US subsidiary of Dr. Reddy’s), initiated a recall of Acid Controller tablets. The tablets relieves ...
DRL-Logo.png

Results: 28 of 50 Nifty Companies Show 0.6% decline in Net Profit for Q4 2016, Annual Growth at 5.4%

Q4 Results are out! As the Nifty 50 companies line up to disclose their performance report, we bring you a summary of their results along with the schedule ...
Nifty-50-Companies-FY16-Results-for-the-year-ended-March-31-2016-28_2.png

March 2016 Results – Dr Reddys, Arvind, Oracle, Vijaya Bank and more

Q4 Results are out! As the companies line up to disclose their performance report, we bring you a daily summary of the previous days results. Here is a quick ...

Premium: US FDA Warning Letter to Dr. Reddy’s – Here is an Additional Update

This is our follow-on newsletter w.r.t the Warning Letters issued by the US FDA to Dr. Reddy’s Laboratories on 6-Nov-15. Let us do a quick recap of what ...

Premium: Dr. Reddy’s stock tank – Here is a breakup of what happened

Dr. Reddy’s Lab tanked on Friday and then again today, after news came out that involved US action against the company. The stock has been in news for 2 ...